产品
编 号：F145148
分子式：C18H21FN3O4.5
分子量：370.38
分子式：C18H21FN3O4.5
分子量：370.38
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
100mg
400
In-stock
5g
760
In-stock
结构图
CAS No: 138199-71-0
产品详情
生物活性：
Levofloxacin hydrate (Levofloxacin hemihydrate) is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin hydrate inhibits the DNA gyrase and topoisomerase IV. Levofloxacin hydrate can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin hydrate shows anti-orthopoxvirus activity.
体内研究：
Levofloxacin (10.7 mg/kg；腹腔注射，每天一次，持续 10 天或 3 周) 时间依赖性地诱导白化小鼠肝脏和心脏的毒性作用。Animal Model:Matured male Albino mice
Dosage:10.7 mg/kg
Administration:Intraperitoneal injection; 10.7 mg/kg, once daily for 10 days or 3 weeks
Result:Induced severe congestion of blood vessels in the portal area, central veins with inflammatory cells infiltration, necrosis with pyknosis of cardiac muscle nuclei and apoptosis, degeneration and necrosis of hepatocytes.
体外研究：
Levofloxacin 对结核分枝杆菌敏感菌株 OFLO、LVFX 和 SPFX 的 MIC50 值分别为 1.0、0.5 和 0.25 μg/mL。
Levofloxacin hydrate (Levofloxacin hemihydrate) is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin hydrate inhibits the DNA gyrase and topoisomerase IV. Levofloxacin hydrate can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin hydrate shows anti-orthopoxvirus activity.
体内研究：
Levofloxacin (10.7 mg/kg；腹腔注射，每天一次，持续 10 天或 3 周) 时间依赖性地诱导白化小鼠肝脏和心脏的毒性作用。Animal Model:Matured male Albino mice
Dosage:10.7 mg/kg
Administration:Intraperitoneal injection; 10.7 mg/kg, once daily for 10 days or 3 weeks
Result:Induced severe congestion of blood vessels in the portal area, central veins with inflammatory cells infiltration, necrosis with pyknosis of cardiac muscle nuclei and apoptosis, degeneration and necrosis of hepatocytes.
体外研究：
Levofloxacin 对结核分枝杆菌敏感菌株 OFLO、LVFX 和 SPFX 的 MIC50 值分别为 1.0、0.5 和 0.25 μg/mL。
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备